The therapeutic potential of 'adult'or at least non‐embryonic stem cells and their progeny
has developed gradually over the past half century as a consequence of the wealth of …

Despite advances in the management of myocardial infarction, congestive heart failure
following myocardial infarction continues to be a major worldwide medical problem …

Soon after the first experimental scientific investigations of cell transplantation in various
animal models of myocardial infarction and left ventricular dysfunction, a growing number of …

Cell-based cardiac therapy is emerging as a potential strategy (1) to address substantial
unmet clinical needs in cardiovascular medicine (2). Unlike all other therapies employed in …

Cardiac performance after myocardial infarction (MI) is compromised by ventricular
remodelling, which represents a major cause of late infarct-related chronic heart failure and …

Aims This randomized study investigates whether bone marrow cells (BMCs) can reduce
ischaemic injury during cardiac surgery. Methods and results Forty-four elective coronary …

The development of postinfarction left ventricular dysfunction, particularly in patients with a
large myocardial infarction, remains a major challenge. Recent experimental studies …

This editorial refers to 'Intracoronary infusion of bone marrow-derived selected
CD34+CXCR4+ cells and nonselected mononuclear cells in patients with acute STEMI and …